The Presidential Daily Brief


  1. dnashutterstock 133184528

    FDA Grants First OK for Personalized Gene Therapy

    Was the solution inside you all along? For the first time, the U.S. Food and Drug Administration has approved a cell-based gene therapy. Called Kymriah, it can now be used to treat acute lymphoblastic leukemia, America’s most common childhood cancer, for patients 25 and younger. It uses a procedure called CAR-T, in which doctors remove a patient’s T-cells, modify them to attack cancerous cells, and return them to the bloodstream. If “living drugs” work, they could transform the fight against disease, and hopefully reduce Kymriah’s $475,000 cost.

This story is part of The Presidential Daily Brief

view full edition